Kalpaklioglu, A.Baccioglu, A.2020-06-252020-06-252017closedAccess0105-45381398-9995https://hdl.handle.net/20.500.12587/6921Congress of the European-Academy-of-Allergy-and-Clinical-Immunology -- JUN 17-21, 2017 -- Helsinki, FINLANDKalpaklioglu, A. Fusun/0000-0002-6548-6932eninfo:eu-repo/semantics/closedAccessResponse to omalizumab in urticaria & asthma: "a life-time together?"Conference Object72418418WOS:000408773103067Q1